Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease-2019

Pierre Antoine Brown, Michaeline McGuinty, Christos Argyropoulos, Edward G Clark, David Colantonio, Pierre Giguere, Swapnil Hiremath
doi: https://doi.org/10.1101/2022.05.18.22275234

Article usage

Article usage: May 2022 to December 2024

AbstractFullPdf
May 2022139215326
Jun 2022147133201
Jul 2022436113202
Aug 20223155096
Sep 20222393267
Oct 20221955164
Nov 20223697678
Dec 2022517271131
Jan 2023241137104
Feb 20231453666
Mar 20231363346
Apr 20231043138
May 2023812530
Jun 2023682134
Jul 2023342022
Aug 2023564225
Sep 2023542115
Oct 2023552816
Nov 2023431210
Dec 202335810
Jan 2024351311
Feb 202417821
Mar 202445910
Apr 20241699
May 202437816
Jun 20241618
Jul 20241917
Aug 20242227
Sep 20241749
Oct 20241358
Nov 202421517
Dec 2024412
Back to top
Posted May 21, 2022.
Download PDF
Data/Code
Email
Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease-2019
Pierre Antoine Brown, Michaeline McGuinty, Christos Argyropoulos, Edward G Clark, David Colantonio, Pierre Giguere, Swapnil Hiremath
medRxiv 2022.05.18.22275234; doi: https://doi.org/10.1101/2022.05.18.22275234
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area